# Kidney Transplant Immunosuppression Dashboard

A **flexdashboard** that compares the safety and efficacy of abatacept conversion versus standard belatacept maintenance in adult kidney transplant recipients.  
**Live demo:** https://github.com/Wen200802/finaldashboard/  

---

## ğŸ“Š Live Dashboard

Open the interactive dashboard here:  
https://github.com/Wen200802/finaldashboard/  

---

## ğŸ”§ Installation

1. **Clone this repository**  
   git clone https://github.com/Wen200802/finaldashboard.git  
   cd finaldashboard  

2. **Install required R packages**  
   Rscript -e 'install.packages(c("flexdashboard", "plotly", "DT", "ggplot2", "htmlwidgets", "dplyr"))'  

3. **Render locally** (optional)  
   Rscript -e 'rmarkdown::run("Final project 4a.Rmd")'
  

---

## ğŸ—‚ï¸ Data

 **Confidential clinical trial data** from a prospective, intentionâ€‘toâ€‘treat, randomized controlled study comparing abatacept conversion vs. belatacept maintenance in kidney transplant patients.  
 - **Sample size:** 86 firstâ€‘time adult renal transplant recipients (â‰¥18 years, any gender/race/ethnicity)  
 - **Collection:** Scheduled blood draws for PK/PD, safety labs, HLA testing, and efficacy assessments at baseline, Month 3, 6, 9, 12, and 24  
 - **Period:** Enrollment over 1.5 years; 24 months followâ€‘up; total study span ~3.5 years  

*(Raw data are confidential and not included.)*

---

## âš™ï¸ Usage

- Navigate to the **â€œDataset Descriptionâ€** tab to review study design and data collection protocol.  
- Hover over any point in the main plot to see patientâ€‘level metrics (arm, timepoint, eGFR, etc.).  
- Use the legend toggles to filter by treatment arm.  

---

## ğŸ”— Source Code

This repository contains the RMarkdown (Final project 4a.Rmd) and all supporting scripts to generate the dashboard widgets.  

---

## ğŸŒŸ Project Impact

This trial addresses a critical need to optimize immunosuppression in kidney transplant patients by comparing abatacept conversion with standard belatacept maintenance. Its findings will inform evidenceâ€‘based guidelines to personalize therapy, improve longâ€‘term graft survival, and minimize treatmentâ€‘related toxicity.  

